Zak A,Zeman M,Slaby A,et al.Xanthomas:clinical and pathophysiological relations[J].Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub,2014,158(2):181-188.
Govorkova M S,Milman T,Ying G S,et al.Inflammatorymeditors in xanthelasma palpebrarum:histopatholgic and immunohistochemical study[J].Ophthalmic Plast Reconstr Surg,2018,34(3):225-230.
[6]
Dey A,Aggarwal R,Dwivedi S.Cardiovascular profile of xanthelasma palpebrarum[J].Bio Med Research Int,2013(2013) :932863.
[7]
Pandhi D,Gupta P,Singal A,et al.Xanthelasma palpebrarum:a marker of premature atherosclerosis(risk of atherosclerosis inxanthelasma)[J].Postgrad Med J,2012,88(1038):198-204.
[8]
Christoffersen M,Tybjaerg H A.Visible aging signs as risk markers for ischemic heart disease:epidemiology,pathogenesis and clinical implications[J].Ageing Res Rev,2016,25(1):24-41.
Simoes P,Vivian W,Isabella O,et al.Xanthelasmapalpebrarum after hyaluronic acid injection in the lower eyelid:A case report and review of the literature[J].J Cosmet Dermatol,2021,20(9):2750-2752
[11]
Nguyen A H,Vaudreuil A M,Huerter C J.Systematic review of laser therapy in xanthelasma palpebrarum [J].Int J Dermatology,2017,56(3):47-55.
[12]
Cannon P S,Ajit R,Leatherbarrow B.Efficacy of trichloroacetic acid(95%) in the management of xanthelasma palpebrarum[J].Clin Exp Dermatol ,2010,35(8):845-848.
2022, Vol. 33 
